Drug-associated inflammatory bowel disease: a real-world pharmacovigilance study using the FAERS and JADER databases - Top-Institutions - MDSpire

Drug-associated inflammatory bowel disease: a real-world pharmacovigilance study using the FAERS and JADER databases

  • By

  • Yuou Ying

  • Mengyuan Shen

  • Jinhan Chen

  • Tongfei Feng

  • Zejiong Li

  • Zhekai Ying

  • Dongdong Yang

  • Ruyi Ju

  • Jiannong Wu

  • July 7, 2026

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Gastroenterology
    • IBD

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, Ohio

    Key Differentiators

    • Gastroenterology
    • IBD

  • #3

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, Maryland

    Key Differentiators

    • Gastroenterology
    • IBD

  • #4

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Gastroenterology
    • IBD

  • #5

    UCLA Medical Center
    UCLA Medical Center

    Los Angeles, California

    Key Differentiators

    • Gastroenterology
    • IBD

Original Source(s)

Drug-associated inflammatory bowel disease: a real-world pharmacovigilance study using the FAERS and JADER databases

  • by Yuou Ying, Mengyuan Shen, Jinhan Chen, Tongfei Feng, Zejiong Li, Zhekai Ying, Dongdong Yang, Ruyi Ju, Jiannong Wu

  • July 7, 2026

Related Content

Integrative single-cell transcriptomics and mendelian randomization identifies BTN3A2 as a shared protective factor in Behçet’s disease and inflammatory bowel disease

RNF213 marks a regulatory T-cell subset associated with ulcerative colitis

Casein hydrolysate promotes intestinal repair in adult mice with Salmonella enteritis through a lactate-GPR81-Wnt3A axis in intestinal stem cell niche